THE RATIONALE FOR DRUG COMBINATIONS IN AGE-RELATED MACULAR DEGENERATION

    loading  Checking for direct PDF access through Ovid

Abstract

The strategies for improving control of age-related macular degeneration with combination therapies are evolving. The focus on more effective blockade of choroidal neovascularization has shifted to include control of additional processes implicated in disease progression, such as neural death, inflammation, or fibrosis. Although there is likely to be a strong interrelationship between choroidal neovascularization and inflammation that contributes to advanced stages of disease progression, including fibrosis, combining treatment strategies may enlarge the opportunity to prevent both early and late vision loss.

Related Topics

    loading  Loading Related Articles